Several studies have demonstrated that PD-1/PD-L1 interaction contributes to chemoresistance in breast cancer by upregulating the expression of MDR-1, implying a potential PD-1/PD-L1-mediated mechanism underlying treatment resistance [23]. The gene discussed is PDCD1; the disease is breast cancer.